413 related articles for article (PubMed ID: 25042737)
1. Infused autograft lymphocyte to monocyte ratio and survival in diffuse large B cell lymphoma.
Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Hogan WJ; Markovic SN
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1804-12. PubMed ID: 25042737
[TBL] [Abstract][Full Text] [Related]
2. Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma.
Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Hogan WJ; Markovic SN
J Blood Med; 2015; 6():45-53. PubMed ID: 25674021
[TBL] [Abstract][Full Text] [Related]
3. Infused autograft lymphocyte-to-monocyte ratio and survival in T-cell lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation.
Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Hogan WJ; Markovic SN
J Hematol Oncol; 2015 Jul; 8():80. PubMed ID: 26138828
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.
Watanabe R; Tomita N; Itabashi M; Ishibashi D; Yamamoto E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Hattori Y; Motohashi K; Takasaki H; Ohshima R; Hashimoto C; Yamazaki E; Fujimaki K; Sakai R; Fujisawa S; Motomura S; Ishigatsubo Y
Eur J Haematol; 2014 Mar; 92(3):204-10. PubMed ID: 24283206
[TBL] [Abstract][Full Text] [Related]
5. Low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in non-germinal center type diffuse large B-cell lymphoma.
Wei X; Huang F; Wei Y; Jing H; Xie M; Hao X; Feng R
Leuk Res; 2014 Jun; 38(6):694-8. PubMed ID: 24713260
[TBL] [Abstract][Full Text] [Related]
6. Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis.
Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Villasboas JC; Markovic SN
Leuk Res; 2019 Jun; 81():1-9. PubMed ID: 30978434
[TBL] [Abstract][Full Text] [Related]
7. The absolute lymphocyte to monocyte ratio is associated with poor prognosis in classical Hodgkin lymphoma patients younger than 60 years of age.
Koh YW; Jung SJ; Yoon DH; Suh C; Cha HJ; Go H; Kim JE; Kim CW; Huh J
Hematol Oncol; 2015 Sep; 33(3):133-40. PubMed ID: 25224646
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes.
Wang J; Gao K; Lei W; Dong L; Xuan Q; Feng M; Wang J; Ye X; Jin T; Zhang Z; Zhang Q
Oncotarget; 2017 Jan; 8(3):5414-5425. PubMed ID: 28036275
[TBL] [Abstract][Full Text] [Related]
9. Should the cut-off values of the lymphocyte to monocyte ratio for prediction of prognosis in diffuse large B-cell lymphoma be changed in elderly patients?
Koh YW; Park CS; Yoon DH; Suh C; Huh J
Eur J Haematol; 2014 Oct; 93(4):340-8. PubMed ID: 24766257
[TBL] [Abstract][Full Text] [Related]
10. CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy.
Keane C; Gill D; Vari F; Cross D; Griffiths L; Gandhi M
Am J Hematol; 2013 Apr; 88(4):273-6. PubMed ID: 23460351
[TBL] [Abstract][Full Text] [Related]
11. The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy.
Rambaldi A; Boschini C; Gritti G; Delaini F; Oldani E; Rossi A; Barbui AM; Caracciolo D; Ladetto M; Gueli A; De Crescenzo A; Passera R; Devizzi L; Patti C; Gianni AM; Tarella C
Am J Hematol; 2013 Dec; 88(12):1062-7. PubMed ID: 23940056
[TBL] [Abstract][Full Text] [Related]
12. Peripheral Blood Lymphocyte-to-Monocyte Ratio at Relapse Predicts Outcome for Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in the Rituximab Era.
Katoh D; Ochi Y; Yabushita T; Ono Y; Hiramoto N; Yoshioka S; Yonetani N; Matsushita A; Hashimoto H; Kaji S; Imai Y; Ishikawa T
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e91-e97. PubMed ID: 28918104
[TBL] [Abstract][Full Text] [Related]
13. Comparison of prognostic impact of absolute lymphocyte count, absolute monocyte count, absolute lymphocyte count/absolute monocyte count prognostic score and ratio in patients with diffuse large B cell lymphoma.
Markovic O; Popovic L; Marisavljevic D; Jovanovic D; Filipovic B; Stanisavljevic D; Matovina-Brko G; Hajder J; Matkovic T; Živkovic R; Stanisavljevic N; Todorović M; Petrovic D; Mihaljevic B
Eur J Intern Med; 2014 Mar; 25(3):296-302. PubMed ID: 24565533
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood lymphocyte to monocyte ratio recovery from low levels at diagnosis after completion of first line therapy predicts good clinical outcomes in patients with diffuse large B-cell lymphoma.
Zhou S; Xu L; Ma Y; Tang L; Zhang Y; Shi Y; Sun L; Chen Y; Liang B; Zhou Y; Yu K; Shen J
Oncotarget; 2017 Mar; 8(12):19556-19565. PubMed ID: 28107187
[TBL] [Abstract][Full Text] [Related]
15. Infused Autograft Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched Case-Control Study.
Porrata LF; Burgstaler EA; Winters JL; Jacob E; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Villasboas J; Paludo J; Markovic SN
Transplant Cell Ther; 2021 Sep; 27(9):769.e1-769.e8. PubMed ID: 34091071
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment lymphocyte-to-monocyte ratios predict AIDS-related diffuse large B-cell lymphoma overall survival.
Zeng J; Zhang X; Jia L; Wu Y; Tian Y; Zhang Y
J Med Virol; 2021 Jun; 93(6):3907-3914. PubMed ID: 33155687
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Lymphocyte/Monocyte Ratio on Clinical Features and Prognosis of Patients with Primary Gastrointestinal Diffuse Large B Cell Lymphoma].
Xu YX; Zhang YG; Xu CL; Liu NJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1404-1409. PubMed ID: 27784365
[TBL] [Abstract][Full Text] [Related]
18. The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma.
Porrata LF; Gertz MA; Geyer SM; Litzow MR; Gastineau DA; Moore SB; Pineda AA; Bundy KL; Padley DJ; Persky D; Lacy MQ; Dispenzieri A; Snow DS; Markovic SN
Leukemia; 2004 Jun; 18(6):1085-92. PubMed ID: 15042106
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil/Lymphocyte Ratio, Lymphocyte/Monocyte Ratio, and Absolute Lymphocyte Count/Absolute Monocyte Count Prognostic Score in Diffuse Large B-Cell Lymphoma: Useful Prognostic Tools in the Rituximab Era.
Ho CL; Lu CS; Chen JH; Chen YG; Huang TC; Wu YY
Medicine (Baltimore); 2015 Jun; 94(24):e993. PubMed ID: 26091479
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and prognosis of the dynamic monitoring lymphocyte to monocyte ratio in patients with diffuse large B-cell lymphoma].
Zhang SN; Li MJ; Yuan FF; Chen L; Mi RH; Wei XD; Song YP; Yin QS
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3139-3144. PubMed ID: 31694104
[No Abstract] [Full Text] [Related]
[Next] [New Search]
